Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (1 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (23)
COVID-19 (6)
Type
(
1 selected
)
Type
Guidance (1858)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (223)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (601)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (339)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (758)
Apply filters
Showing 221 to 230 of 1858
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Botulinum toxin type A injections into the urethral sphincter for idiopathic chronic non-obstructive urinary retention
IPG766
28 June 2023
28 June 2023
Botulinum toxin type A for the prevention of headaches in adults with chronic migraine
TA260
27 June 2012
27 June 2012
Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision
IPG268
23 July 2008
23 July 2008
Brain tumours (primary) and brain metastases in over 16s
NG99
11 July 2018
29 January 2021
Breast reconstruction using lipomodelling after breast cancer treatment
IPG417
23 January 2012
23 January 2012
Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphoma
TA577
24 April 2019
24 April 2019
Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma
TA524
13 June 2018
13 June 2018
Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphoma
TA478
4 October 2017
4 October 2017
Brentuximab vedotin for untreated advanced Hodgkin lymphoma (terminated appraisal)
TA594
14 August 2019
14 August 2019
Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphoma
TA641
12 August 2020
12 August 2020
Previous page
1
…
21
22
Current page
23
24
25
…
186
Page
23
of
186
Next page
Results per page
10
25
50
All
Back to top